Creating the “new normal” post-Coronavirus world—web-communication replacing face-to-face interaction Wolfgang HilbeAndreas PircherRupert Bartsch editorial 21 September 2020 Pages: 245 - 246
Rectal cancer: latest developments and innovative new treatment concepts Arno Amann editorial 21 September 2020 Pages: 251 - 252
Therapies in flux: highlights of the 2019 San Antonio Breast Cancer Symposium (SABCS) Simon Peter Gampenrieder editorial 21 September 2020 Pages: 253 - 254
Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo? Semir Beslija editorial 21 September 2020 Pages: 255 - 256
Fine-tuning front-line therapy in chronic lymphocytic leukemia Jan-Paul BohnDominik Wolf short review Open access 19 May 2020 Pages: 259 - 265
ASH highlights 2019: “aggressive B-cell lymphoma” Clemens A. Schmitt short review Open access 20 May 2020 Pages: 266 - 269
Myeloid diseases—Chronic Myeloid Leukemia (CML)—report from ASH 2019 on new developments Andreas L. Petzer short review 26 May 2020 Pages: 276 - 279
New systemic treatment options in mycosis fungoides and Sézary syndrome Magdalena Seidl-PhilippVan Anh Nguyen short review Open access 20 May 2020 Pages: 280 - 284
Patient-reported outcomes and psycho-oncological screening in hematology: a practical example of routine electronic monitoring Jens LehmannLisa M. WintnerBernhard Holzner review Open access 03 July 2020 Pages: 285 - 293
Comparison of outcomes of two non-BCNU-containing conditioning regimens used in autologous stem cell transplantation for relapsed/refractory lymphoma Amro Mohamed Sedky El-GhammazMaha El-ZimaityAfaf Abdel-Aziz Abdel-Ghaffar original report 25 May 2020 Pages: 294 - 300
Adjuvant and neoadjuvant treatment of melanoma Peter Koelblinger short review Open access 15 April 2020 Pages: 301 - 305
The therapeutic landscape of advanced melanoma Erika Richtig short review Open access 15 April 2020 Pages: 306 - 308
The future of combination therapies in advanced melanoma Christoph Hoeller short review Open access 14 August 2020 Pages: 309 - 313
Rectal cancer among younger Egyptian patients—clinico-pathological features and oncologic outcomes: A single institution experience Amir M. ZaidEngy M. AboelnagaIslam H. Metwally original report 26 May 2020 Pages: 314 - 323
Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer Fabian LungerGeorgios Peros short review 13 March 2020 Pages: 324 - 328
Neoadjuvant chemoradiotherapy in rectal cancer Christoph Reinhold ArnoldJulian MangesiusUte Ganswindt short review Open access 15 April 2020 Pages: 329 - 333
Circulating tumour DNA-guided adjuvant chemotherapy in colorectal carcinoma Andreas ReichingerHolger Rumpold short review 16 April 2020 Pages: 334 - 336
Four lines of immunochemotherapy combinations in a young patient with an aggressive metastatic colorectal cancer Frédéric H. WitteWolfgang HilbeErcan Müldür case report 30 June 2020 Pages: 337 - 340
San Antonio Breast Cancer Symposium 2019: human epidermal growth factor receptor 2(HER2)-positive breast cancer and image-guided biopsy to detect pathologic complete response (pCR) Clemens Dormann short review 13 July 2020 Pages: 341 - 345
Treatment options in early triple-negative breast cancer Christoph SuppanMarija Balic short review Open access 07 May 2020 Pages: 346 - 348
San Antonio 2019: interesting topics for daily clinical practice in breast cancer Arik Galid short review Open access 01 September 2020 Pages: 349 - 352
Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors Osamu TanakaNorihiko FunaguchiMasayuki Matsuo original report 25 May 2020 Pages: 353 - 356